Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors

被引：1
|
作者：
Kim, Sung Han [1 ,2 ]
Lerner, Seth P. P. [2 ,3 ]
机构：
[1] Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Goyang, South Korea
[2] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX USA
[3] Baylor Coll Med Med Ctr, Fac Affairs, Scott Dept Urol, Beth & Dave Swalm Chair Urol Oncol, 7200 Cambridge,MC BCM380, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 02期
关键词：
INTRAVESICAL MITOMYCIN-C; DIAGNOSIS; EFFICACY;
D O I：
10.1200/JCO.22.02104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / +
页数：5
相关论文
共 50 条
  • [41] Risk stratification using hotspot genotyping in low-grade serous ovarian cancer
    Wohlmuth, C.
    Tone, A.
    Daghrach, A.
    Stickle, N.
    Virtanen, C.
    Brown, T. J.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 36 - 37
  • [42] A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases
    Akitake, Masakazu
    Kiyoshima, Keijiro
    Yokomizo, Akira
    Shiga, Kenichiro
    Koga, Hirofumi
    Takeuchi, Ario
    Shiota, Masaki
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Yamaguchi, Akito
    Eto, Masatoshi
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (06) : 785 - 790
  • [43] Innovative Technique in Nonmuscle Invasive Bladder Cancer-Bipolar Plasma Vaporization
    Geavlete, Bogdan
    Multescu, Razvan
    Georgescu, Dragos
    Jecu, Marian
    Dragutescu, Mihai
    Geavlete, Petrisor
    UROLOGY, 2011, 77 (04) : 849 - 854
  • [44] Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)
    Matulay, Justin T.
    Soloway, Mark
    Witjes, J. Alfred
    Buckley, Roger
    Persad, Raj
    Lamm, Donald L.
    Boehle, Andreas
    Palou, Joan
    Colombel, Marc
    Brausi, Maurizio
    Kamat, Ashish M.
    BJU INTERNATIONAL, 2020, 125 (04) : 497 - 505
  • [45] Real-World Outcomes Driving the Needle toward Simplification of Nonmuscle Invasive Bladder Cancer Risk Stratification
    Huelster, Heather L.
    Sexton, Wade J.
    JOURNAL OF UROLOGY, 2022, 208 (02): : 239 - 240
  • [46] Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
    Hall, M. Craig
    Chang, Sam S.
    Dalbagni, Guido
    Pruthi, Raj Som
    Seigne, John Derek
    Skinner, Eila Curlee
    Wolf, J. Stuart, Jr.
    Schellhammer, Paul F.
    JOURNAL OF UROLOGY, 2007, 178 (06): : 2314 - 2330
  • [47] Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS)
    Smith, JA
    Labasky, RF
    Cockett, ATK
    Fracchia, JA
    Montie, JE
    Rowland, RG
    JOURNAL OF UROLOGY, 1999, 162 (05): : 1697 - 1701
  • [48] EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification
    Wang, Hui
    Ding, Weihong
    Jiang, Guangliang
    Gou, Yuancheng
    Sun, Chuanyu
    Chen, Zhongqing
    Xu, Ke
    Xia, Guowei
    MEDICINE, 2018, 97 (36)
  • [49] Is Office-based Management of Intermediate-risk Low-grade Non-muscle-invasive Bladder Cancer Ready For Prime Time?
    Taylor, Jacob
    Lotan, Yair
    EUROPEAN UROLOGY, 2023, 83 (02) : 131 - 132
  • [50] Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)
    Contieri, Roberto
    Soloway, Mark S.
    Gontero, Paolo
    Herr, Harry
    Kassouf, Wassim
    Mertens, Laura S.
    Moschini, Marco
    O'Donnell, Michael
    Palou, Joan
    Psutka, Sarah P.
    Roupret, Morgan
    Teoh, Jeremy Y. C.
    Kamat, Ashish M.
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (01): : 179 - 189
12345